Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Parabiosis and single-cell RNA sequencing reveal a limited contribution of monocytes to myofibroblasts in kidney fibrosis
Rafael Kramann, Flavia Machado, Haojia Wu, Tetsuro Kusaba, Konrad Hoeft, Rebekka K. Schneider, Benjamin D. Humphreys
Rafael Kramann, Flavia Machado, Haojia Wu, Tetsuro Kusaba, Konrad Hoeft, Rebekka K. Schneider, Benjamin D. Humphreys
View: Text | PDF
Research Article Nephrology

Parabiosis and single-cell RNA sequencing reveal a limited contribution of monocytes to myofibroblasts in kidney fibrosis

  • Text
  • PDF
Abstract

Fibrosis is the common final pathway of virtually all chronic injury to the kidney. While it is well accepted that myofibroblasts are the scar-producing cells in the kidney, their cellular origin is still hotly debated. The relative contribution of proximal tubular epithelium and circulating cells, including mesenchymal stem cells, macrophages, and fibrocytes, to the myofibroblast pool remains highly controversial. Using inducible genetic fate tracing of proximal tubular epithelium, we confirm that the proximal tubule does not contribute to the myofibroblast pool. However, in parabiosis models in which one parabiont is genetically labeled and the other is unlabeled and undergoes kidney fibrosis, we demonstrate that a small fraction of genetically labeled renal myofibroblasts derive from the circulation. Single-cell RNA sequencing confirms this finding but indicates that these cells are circulating monocytes, express few extracellular matrix or other myofibroblast genes, and express many proinflammatory cytokines. We conclude that this small circulating myofibroblast progenitor population contributes to renal fibrosis by paracrine rather than direct mechanisms.

Authors

Rafael Kramann, Flavia Machado, Haojia Wu, Tetsuro Kusaba, Konrad Hoeft, Rebekka K. Schneider, Benjamin D. Humphreys

×

Figure 2

Parabiosis with genetic fate tracing to dissect the contribution of circulating cells to kidney fibrosis.

Options: View larger image (or click on image) Download as PowerPoint
Parabiosis with genetic fate tracing to dissect the contribution of circ...
(A) Rosa26CreER;tdTomato mice (n = 8; all females, 8 week of age) received tamoxifen (4 × 10 mg p.o. every other day) to genetically tag all cells and were conjoined with B6.SJL (CD45.1) mice at 10 days after the last tamoxifen dose. Four weeks after parabiosis surgery the B6.SJL parabiont was subjected to unilateral ureteral obstruction (UUO) surgery to induce kidney fibrosis. Mice were sacrificed 10 days after UUO surgery. n = 2 mice died during the experiment; final data represent n = 6 parabiosis pairs in all readouts. MF, myofibroblast. (B) Representative flow cytometric plot and quantification of CD45.1+ versus CD45.2+ cells in the blood of the B6.SJL (CD45.1) parabiont at 4 weeks after parabiosis surgery. (C) Representative flow cytometric plot and quantification of recombination efficiency (i.e., tdTomato+) of CD45.2+ cells in the blood of the B6.SJL parabiont at 4 weeks after parabiosis surgery. (D) Representative flow cytometric plots and quantification of CD45.1+ versus CD45.2+ cells in the spleen of the B6.SJL (CD45.1) parabiont after sacrifice. (E) Representative flow cytometric plot and quantification of recombination efficiency (i.e., tdTomato+) of CD45.2+ cells in the spleen of the B6.SJL parabiont after sacrifice. (F–H) Representative flow cytometric plots and quantification of CD45.1+ versus CD45.2+ leukocyte influx into the contralateral noninjured (CLK) and fibrotic UUO kidneys. All data represent mean ± SD. **P < 0.01 by unpaired t test; n = 6 in each graph.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts